Nisa Investment Advisors
OCUL icon

Nisa Investment Advisors’s Ocular Therapeutix OCUL Stock Holding History

Nisa Investment Advisors’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$45K Buy
5,312
+1,708
+47% +$16.3K ﹤0.01% 1709
2025
Q4 		$43.8K Hold
3,604
– – ﹤0.01% 1659
2025
Q3 		$42.1K Hold
3,604
– – ﹤0.01% 1679
2025
Q2 		$33.4K Buy
3,604
+1,392
+63% +$10.9K ﹤0.01% 1720
2025
Q1 		$16.2K Buy
2,212
+128
+6% +$984 ﹤0.01% 1965
2024
Q4 		$17.8K Buy
2,084
+137
+7% +$1.34K ﹤0.01% 1970
2024
Q3 		$16.9K Sell
1,947
-406
-17% -$3.35K ﹤0.01% 1961
2024
Q2 		$16.1K Buy
2,353
+30
+1% +$185 ﹤0.01% 2017
2024
Q1 		$21.1K Buy
2,323
+133
+6% +$944 ﹤0.01% 1868
2023
Q4 		$9.77K Sell
2,190
-5,882
-73% -$17.4K ﹤0.01% 2046
2023
Q3 		$25.3K Hold
8,072
– – ﹤0.01% 1938
2023
Q2 		$41.7K Buy
8,072
+2,500
+45% +$14.9K ﹤0.01% 1807
2023
Q1 		$29K Hold
5,572
– – ﹤0.01% 1890
2022
Q4 		$16K Buy
5,572
+72
+1% +$238 ﹤0.01% 2112
2022
Q3 		$20K Hold
5,500
– – ﹤0.01% 2053
2022
Q2 		$22K Buy
5,500
+5,000
+1,000% +$18.9K ﹤0.01% 2024
2022
Q1 		$2K Hold
500
– – ﹤0.01% 2345
2021
Q4 		$3K Hold
500
– – ﹤0.01% 2117
2021
Q3 		$5 Hold
500
– – ﹤0.01% 2259
2021
Q2 		$7 Hold
500
– – ﹤0.01% 2261
2021
Q1 		$8 Buy
+500
New +$9.63K ﹤0.01% 2232

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Nisa Investment Advisors's OCUL Position: Q1 2026 in Review

Nisa Investment Advisors increased its Ocular Therapeutix (OCUL) stake by 47% in Q1 2026, buying an estimated $16.3K and bringing the position to 5,312 shares worth $45K. The position accounts for ﹤0.01% of the portfolio, ranked #1709.

Nisa Investment Advisors first reported a position in OCUL in Q1 2021 and has held it in 21 quarters since. 269 funds tracked by Wall St. Rank hold OCUL as of Q1 2026.

  • Nisa Investment Advisors held 5,312 shares of Ocular Therapeutix worth $45K as of Q1 2026.
  • Nisa Investment Advisors bought 1,708 Ocular Therapeutix shares in Q1 2026, an estimated $16.3K.
  • Ocular Therapeutix made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #1709 holding.
  • Nisa Investment Advisors first reported a position in Ocular Therapeutix in Q1 2021 and has held it in 21 quarters since.
  • 269 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.